Get started
Author

Rehman Qureshi

Observed names: Qureshi Rehman, R Qureshi, Rehman A Qureshi, Rehman A. Qureshi, Rehman Ahmed Qureshi, Rehman Quereshi
OpenAlex ID: A5114045758
Functional significance of macrophage-derived exosomes in inflammation and pain
2014 · Marguerite K. McDonald, Yuzhen Tian, et al. · Pain · 319
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
2025 · Kim A. Reiss, Mathew G. Angelos, et al. · Nature Medicine · 249
MicroRNA modulation in complex regional pain syndrome
2011 · Irina A Orlova, Guillermo M Alexander, et al. · Journal of Translational Medicine · 165
PDF
Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models
2025 · Stefano Pierini, Rashid Gabbasov, et al. · Nature Communications · 111
PDF
A novel method for the normalization of microRNA RT-PCR data
2013 · Rehman Qureshi, Ahmet Sacan · BMC Medical Genomics · 48
PDF
A phase 1, first-in-human (FIH) study of the anti-HER2 CAR macrophage CT-0508 in subjects with HER2 overexpressing solid tumors.
2022 · Kim Anna Reiss, Yuan Yuan, et al. · Journal of Clinical Oncology · 47
Analgesic Response to Intravenous Ketamine Is Linked to a Circulating microRNA Signature in Female Patients With Complex Regional Pain Syndrome
2015 · Sabrina R. Douglas, Botros B. Shenoda, et al. · Journal of Pain · 46
PDF
A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT
2018 · Andrew V. Kossenkov, Rehman Qureshi, et al. · Cancer Research · 45
Recursive Cluster Elimination based Rank Function (SVM-RCE-R) implemented in KNIME
2021 · Malik Yousef, Burcu Bakir-Gungor, et al. · F1000Research · 35
PDF
Circulating microRNA Signatures in Rodent Models of Pain
2015 · Rehman A. Qureshi, Yuzhen Tian, et al. · Molecular Neurobiology · 34
Weighted set enrichment of gene expression data
2013 · Rehman Qureshi, Ahmet Sacan · BMC Systems Biology · 25
PDF
Recursive Cluster Elimination based Rank Function (SVM-RCE-R) implemented in KNIME
2020 · Malik Yousef, Burcu Bakir-Gungor, et al. · F1000Research · 24
PDF
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer
2021 · Arlene E. Garcia‐Soto, Nathalie D. McKenzie, et al. · Cancer · 18
PDF
Data simulation and regulatory network reconstruction from time-series microarray data using stepwise multiple linear regression
2012 · Yiqian Zhou, Rehman Qureshi, et al. · Network Modeling Analysis in Health Informatics and Bioinformatics · 17
PDF
Protein surface representation and analysis by dimension reduction
2012 · Heng Yang, Rehman Qureshi, et al. · Proteome Science · 16
PDF
In Vivo CAR-T Therapies—A New Era of Programmable Immunity
2026 · Stefano Pierini, Rehman Qureshi, et al. · International Journal of Molecular Sciences · 11
PDF
951 A phase 1 first in human study of adenovirally transduced anti-HER2 CAR macrophages in subjects with HER2 overexpressing solid tumors: preliminary safety, pharmacokinetics, and TME reprogramming data
2021 · Kim Reiss, Yuan Yuan, et al. · 11
PDF
Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models
2025 · Stefano Pierini, Rashid Gabbasov, et al. · Nature Communications · 8
371 Chimeric antigen receptor macrophages (CAR-M) sensitize solid tumors to anti-PD1 immunotherapy
2022 · Stefano Pierini, Rashid Gabbasov, et al. · Regular and Young Investigator Award Abstracts · 7
PDF
634 A phase 1, first-in-human (FIH) clinical trial of the anti-HER2 CAR macrophage CT-0508 in participants with HER2 overexpressing solid tumors
2022 · Kim Reiss, Yuan Yuan, et al. · Regular and Young Investigator Award Abstracts · 7
PDF
Abstract PO2-04-08: Translational insights from a phase 1, first-in-human (FIH) clinical trial of the anti-HER2 CAR macrophage CT-0508 in participants with HER2 positive metastatic breast cancer and other HER2 overexpressing solid tumors
2024 · Yara Abdou, Joanne Mortimer, et al. · Cancer Research · 6
315 Characterization of CT-0508, an anti-HER2 chimeric antigen receptor macrophage (CAR-M), manufactured from patients enrolled in the phase 1, first in human, clinical trial of CT-0508
2022 · Michael Ball, Madison Kremp, et al. · Regular and Young Investigator Award Abstracts · 6
PDF
318 Pre-clinical development of a CAR monocyte platform for cancer immunotherapy
2022 · Linara Gabitova, Brett Menchel, et al. · Regular and Young Investigator Award Abstracts · 6
PDF
Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
2020 · Makan Khoshnejad, Alfredo Perales-Puchalt, et al. · Molecular Therapy — Methods & Clinical Development · 5
PDF
DNA-Encoded Glutamine Synthetase Enzyme as Ammonia-Lowering Therapeutic for Hyperammonemia
2020 · Makan Khoshnejad, Yaya Dia, et al. · Nucleic Acid Therapeutics · 4
Works count: 56
Citation count: 1,291
H-index: 15
I10-index: 17
Year
Topic
Type